LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: Pediatric P-ANCA vasculitis following COVID-19.

    Fireizen, Yaron / Shahriary, Cyrus / Imperial, Maria E / Randhawa, Inderpal / Nianiaris, Nastasia / Ovunc, Bugsu

    Pediatric pulmonology

    2021  Volume 56, Issue 10, Page(s) 3422–3424

    Abstract: Background: Perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) are associated with a multisystem vasculitis affecting small blood vessels in the body. A handful of adult patients who developed vasculitis post-COVID-19 have been reported. ... ...

    Abstract Background: Perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) are associated with a multisystem vasculitis affecting small blood vessels in the body. A handful of adult patients who developed vasculitis post-COVID-19 have been reported. Although SARS-CoV-2 has been shown to drive an exaggerated immune response in the pediatric population, such as in Multisystem Inflammatory Syndrome in Children (MIS-C), only one case of vasculitis following COVID-19 has been reported previously in children.
    Case presentation: Seventeen-year-old male with a past medical history of COVID-19 pneumonia two months prior presented with acute kidney injury and diffuse alveolar hemorrhage. Rheumatologic workup revealed P-ANCA and Myeloperoxidase (MPO) positivity. Kidney biopsy showed necrotizing glomerulonephritis with limited immune complex deposition. Subsequently, he was treated with steroids and plasmapheresis, and ultimately started on cyclophosphamide.
    Conclusions: To our knowledge, this report presents the second reported pediatric case of P-ANCA/MPO vasculitis following COVID-19.
    MeSH term(s) Adolescent ; Adult ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology ; Antibodies, Antineutrophil Cytoplasmic ; COVID-19/diagnosis ; COVID-19/immunology ; COVID-19/virology ; Child ; Humans ; Male ; Peroxidase ; SARS-CoV-2/immunology ; SARS-CoV-2/pathogenicity ; Systemic Inflammatory Response Syndrome ; Treatment Outcome ; Vasculitis/diagnosis ; Vasculitis/etiology
    Chemical Substances Antibodies, Antineutrophil Cytoplasmic ; Peroxidase (EC 1.11.1.7)
    Language English
    Publishing date 2021-08-11
    Publishing country United States
    Document type Case Reports
    ZDB-ID 632784-9
    ISSN 1099-0496 ; 8755-6863
    ISSN (online) 1099-0496
    ISSN 8755-6863
    DOI 10.1002/ppul.25612
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Mutation analysis of NPHS1 in a worldwide cohort of congenital nephrotic syndrome patients.

    Ovunc, Bugsu / Ashraf, Shazia / Vega-Warner, Virginia / Bockenhauer, Detlef / Elshakhs, Neveen A Soliman / Joseph, Mark / Hildebrandt, Friedhelm

    Nephron. Clinical practice

    2012  Volume 120, Issue 3, Page(s) c139–46

    Abstract: Background: Congenital nephrotic syndrome (CNS) is defined as nephrotic syndrome that manifests within the first 3 months of life. Mutations in the NPHS1 gene encoding nephrin, are a major cause for CNS. Currently, more than 173 different mutations of ... ...

    Abstract Background: Congenital nephrotic syndrome (CNS) is defined as nephrotic syndrome that manifests within the first 3 months of life. Mutations in the NPHS1 gene encoding nephrin, are a major cause for CNS. Currently, more than 173 different mutations of NPHS1 have been published as causing CNS, affecting most exons.
    Methods: We performed mutation analysis of NPHS1 in a worldwide cohort of 20 families (23 children) with CNS. All 29 exons of the NPHS1 gene were examined using direct sequencing. New mutations were confirmed by demonstrating their absence in 96 healthy control individuals.
    Results: We detected disease-causing mutations in 9 of 20 families (45%). Seven of the families showed a homozygous mutation, while two were compound heterozygous. In another 2 families, single heterozygous NPHS1 mutations were detected. Out of 10 different mutations discovered, 3 were novel, consisting of 1 splice site mutation and 2 missense mutations.
    Conclusion: Our data demonstrate that the spectrum of NPHS1 mutations is still expanding, involving new exons, in patients from a diverse ethnic background.
    MeSH term(s) Asian Continental Ancestry Group/genetics ; Case-Control Studies ; Cohort Studies ; DNA Mutational Analysis ; European Continental Ancestry Group/genetics ; Exons/genetics ; Female ; Heterozygote ; Homozygote ; Humans ; Infant ; Infant, Newborn ; Male ; Membrane Proteins/genetics ; Nephrotic Syndrome/congenital ; Nephrotic Syndrome/genetics
    Chemical Substances Membrane Proteins ; nephrin
    Language English
    Publishing date 2012-05-11
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 207121-6
    ISSN 1660-2110 ; 1423-0186 ; 2235-3186 ; 1660-8151 ; 0028-2766
    ISSN (online) 1660-2110 ; 1423-0186 ; 2235-3186
    ISSN 1660-8151 ; 0028-2766
    DOI 10.1159/000337379
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Quality metrics in cardiac catheterization for congenital heart disease: utility of 30-day mortality.

    Backes, Carl H / Bergersen, Lisa / Rome, Jonathan J / Batlivala, Sarosh P / Glatz, Andrew C / Ovunc, Bugsu / David, Sthuthi / Rivera, Brian K / Haque, Urbee / Kollins, Kevin / Yin, Han / Holzer, Ralf J

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

    2015  Volume 85, Issue 1, Page(s) 104–110

    Abstract: Objectives: To characterize the frequency and attributability of death among patients who died within 30 days of their cardiac catheterization (30-day mortality).: Background: 30-day postprocedure mortality is commonly used as a quality outcome ... ...

    Abstract Objectives: To characterize the frequency and attributability of death among patients who died within 30 days of their cardiac catheterization (30-day mortality).
    Background: 30-day postprocedure mortality is commonly used as a quality outcome metric in national cardiac catheterization registries. It is unclear if this parameter is sufficiently specific to meaningfully capture mortality attributable to cardiac catheterization in patients with congenital heart disease (CHD).
    Methods: Multicenter cohort study with 3 participating centers. Records were retrospectively reviewed for patients who died within 30 days of catheterization (06/2007-06/2012). Attributability of death was assigned to each case.
    Results: A total of 14,707 cardiac catheterization procedures were performed during the study period. Death occurred within 30 days in 279/14,707 (1.9%) of cases. Among the patients who died, 53% of cases were emergent or urgent cases. The median age was 4 mos (1 day-45 years). Death was attributable to the catheterization procedure in 29/279 (10%) of cases. Death was attributable to cardiac surgery in 14%, precatheterization clinical status in 34%, postcatheterization clinical status in 22%, and noncardiac comorbidity in 19%. In 1%, death attributability could not be established.
    Conclusions: While valuable in adult settings, 30-day mortality is inadequate as a quality metric among patients with CHD undergoing cardiac catheterization. To derive the optimal benefit from catheterization registry data, more robust methodologies to capture procedure-related mortality are needed. © 2014 Wiley Periodicals, Inc.
    MeSH term(s) Adolescent ; Adult ; Cardiac Catheterization/adverse effects ; Cardiac Catheterization/mortality ; Cardiac Catheterization/standards ; Cardiac Surgical Procedures/adverse effects ; Cardiac Surgical Procedures/mortality ; Cause of Death ; Child ; Child, Preschool ; Comorbidity ; Female ; Heart Defects, Congenital/diagnosis ; Heart Defects, Congenital/mortality ; Heart Defects, Congenital/therapy ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Predictive Value of Tests ; Quality Indicators, Health Care/standards ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; United States ; Young Adult
    Language English
    Publishing date 2015-01-01
    Publishing country United States
    Document type Journal Article ; Multicenter Study
    ZDB-ID 1459995-8
    ISSN 1522-726X ; 1522-1946
    ISSN (online) 1522-726X
    ISSN 1522-1946
    DOI 10.1002/ccd.25683
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.

    Chernin, Gil / Vega-Warner, Virginia / Schoeb, Dominik S / Heeringa, Saskia F / Ovunc, Bugsu / Saisawat, Pawaree / Cleper, Roxana / Ozaltin, Fatih / Hildebrandt, Friedhelm

    Clinical journal of the American Society of Nephrology : CJASN

    2010  Volume 5, Issue 9, Page(s) 1655–1662

    Abstract: Background and objectives: The risk of developing Wilms tumor (WT) can be present or absent in patients with nephrotic syndrome (NS) caused by WT1 mutations. Here, the genotype/phenotype correlation regarding the outcome and risk for WT in 52 patients ... ...

    Abstract Background and objectives: The risk of developing Wilms tumor (WT) can be present or absent in patients with nephrotic syndrome (NS) caused by WT1 mutations. Here, the genotype/phenotype correlation regarding the outcome and risk for WT in 52 patients from 51 families with NS due to WT1 mutations is described.
    Design, setting, participants, & measurements: This study followed 19 patients with mutations in intron 9 splice donor site (KTS mutations), 27 patients with missense mutations, 4 patients with nonsense mutations, 1 patient with a splice site mutation in intron 8, and 1 patient with a deletion.
    Results: Twenty-four different WT1 mutations were detected. Sixteen of the 19 patients with KTS mutations were females. These patients had isolated NS if karyotype was 46,XX and Frasier syndrome if karyotype was 46,XY. Patients with KTS mutations presented at a significantly older age and with a slower progression toward chronic kidney disease (CKD) stage 5, compared with missense mutations. Patients with nonsense mutations presented initially with WT. Six patients with missense mutations developed WT after the diagnosis of NS (interval-range from NS onset to WT of 0.1 to 1.4 years).
    Conclusions: (1) KTS mutations cause isolated NS with absence of WT in 46,XX females. (2) KTS mutations cause Frasier syndrome with gonadoblastoma risk in 46,XY phenotypic females. (3) KTS mutations cause NS with a slower progression when compared with missense mutations. (4) Missense mutations can occur with and without WT. (5) WT1 analysis is important in young patients with NS for early detection and tumor prophylaxis.
    MeSH term(s) Age of Onset ; Child ; Child, Preschool ; Codon, Nonsense ; DNA Mutational Analysis ; Disease Progression ; Female ; Frasier Syndrome/ethnology ; Frasier Syndrome/genetics ; Frasier Syndrome/mortality ; Genes, Wilms Tumor ; Genetic Association Studies ; Genetic Predisposition to Disease ; Gonadoblastoma/ethnology ; Gonadoblastoma/genetics ; Gonadoblastoma/mortality ; Humans ; Infant ; Introns ; Israel ; Kaplan-Meier Estimate ; Karyotyping ; Kidney Failure, Chronic/ethnology ; Kidney Failure, Chronic/genetics ; Kidney Failure, Chronic/mortality ; Kidney Neoplasms/ethnology ; Kidney Neoplasms/genetics ; Kidney Neoplasms/mortality ; Male ; Mutation ; Mutation, Missense ; Nephrotic Syndrome/ethnology ; Nephrotic Syndrome/genetics ; Nephrotic Syndrome/mortality ; Pedigree ; Phenotype ; Risk Assessment ; Risk Factors ; Sequence Deletion ; Time Factors ; Turkey ; United States ; Wilms Tumor/ethnology ; Wilms Tumor/genetics ; Wilms Tumor/mortality
    Chemical Substances Codon, Nonsense
    Language English
    Publishing date 2010-07-01
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2226665-3
    ISSN 1555-905X ; 1555-9041
    ISSN (online) 1555-905X
    ISSN 1555-9041
    DOI 10.2215/CJN.09351209
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Exome sequencing reveals cubilin mutation as a single-gene cause of proteinuria.

    Ovunc, Bugsu / Otto, Edgar A / Vega-Warner, Virginia / Saisawat, Pawaree / Ashraf, Shazia / Ramaswami, Gokul / Fathy, Hanan M / Schoeb, Dominik / Chernin, Gil / Lyons, Robert H / Yilmaz, Engin / Hildebrandt, Friedhelm

    Journal of the American Society of Nephrology : JASN

    2011  Volume 22, Issue 10, Page(s) 1815–1820

    Abstract: In two siblings of consanguineous parents with intermittent nephrotic-range proteinuria, we identified a homozygous deleterious frameshift mutation in the gene CUBN, which encodes cubulin, using exome capture and massively parallel re-sequencing. The ... ...

    Abstract In two siblings of consanguineous parents with intermittent nephrotic-range proteinuria, we identified a homozygous deleterious frameshift mutation in the gene CUBN, which encodes cubulin, using exome capture and massively parallel re-sequencing. The mutation segregated with affected members of this family and was absent from 92 healthy individuals, thereby identifying a recessive mutation in CUBN as the single-gene cause of proteinuria in this sibship. Cubulin mutations cause a hereditary form of megaloblastic anemia secondary to vitamin B(12) deficiency, and proteinuria occurs in 50% of cases since cubilin is coreceptor for both the intestinal vitamin B(12)-intrinsic factor complex and the tubular reabsorption of protein in the proximal tubule. In summary, we report successful use of exome capture and massively parallel re-sequencing to identify a rare, single-gene cause of nephropathy.
    MeSH term(s) Exome ; Frameshift Mutation ; Genes, Recessive ; Homozygote ; Humans ; Proteinuria/genetics ; Receptors, Cell Surface/genetics
    Chemical Substances Receptors, Cell Surface ; intrinsic factor-cobalamin receptor
    Language English
    Publishing date 2011-09-08
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1085942-1
    ISSN 1533-3450 ; 1046-6673
    ISSN (online) 1533-3450
    ISSN 1046-6673
    DOI 10.1681/ASN.2011040337
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Mutation Analysis of NPHS1 in a Worldwide Cohort of Congenital Nephrotic Syndrome Patients

    Ovunc, Bugsu / Ashraf, Shazia / Vega-Warner, Virginia / Bockenhauer, Detlef / Soliman Elshakhs, Neveen A. / Joseph, Mark / Hildebrandt, Friedhelm

    Nephron Clinical Practice

    2012  Volume 120, Issue 3, Page(s) c139–c146

    Abstract: Background: Congenital nephrotic syndrome (CNS) is defined as nephrotic syndrome that manifests within the first 3 months of life. Mutations in the NPHS1 gene encoding nephrin, are a major cause for CNS. Currently, more than 173 different mutations of ... ...

    Abstract Background: Congenital nephrotic syndrome (CNS) is defined as nephrotic syndrome that manifests within the first 3 months of life. Mutations in the NPHS1 gene encoding nephrin, are a major cause for CNS. Currently, more than 173 different mutations of NPHS1 have been published as causing CNS, affecting most exons. Methods: We performed mutation analysis of NPHS1 in a worldwide cohort of 20 families (23 children) with CNS. All 29 exons of the NPHS1 gene were examined using direct sequencing. New mutations were confirmed by demonstrating their absence in 96 healthy control individuals. Results: We detected disease-causing mutations in 9 of 20 families (45%). Seven of the families showed a homozygous mutation, while two were compound heterozygous. In another 2 families, single heterozygous NPHS1 mutations were detected. Out of 10 different mutations discovered, 3 were novel, consisting of 1 splice site mutation and 2 missense mutations. Conclusion: Our data demonstrate that the spectrum of NPHS1 mutations is still expanding, involving new exons, in patients from a diverse ethnic background.
    Keywords Mutation analysis ; Congenital nephrotic syndrome ; NPHS1
    Language English
    Publisher S. Karger AG
    Publishing place Basel
    Publishing country Switzerland
    Document type Article ; Online
    ZDB-ID 207121-6
    ISSN 1660-2110 ; 1423-0186 ; 0028-2766 ; 1660-8151 ; 1660-2110 ; 0028-2766 ; 1660-8151
    ISSN (online) 1660-2110 ; 1423-0186
    ISSN 1660-2110 ; 0028-2766 ; 1660-8151
    DOI 10.1159/000337379
    Database Karger publisher's database

    More links

    Kategorien

  7. Article: Mutation Analysis of ; in a Worldwide Cohort of Congenital Nephrotic Syndrome Patients

    Ovunc, Bugsu / Ashraf, Shazia / Vega-Warner, Virginia / Bockenhauer, Detlef / Soliman Elshakhs, Neveen A. / Joseph, Mark / Hildebrandt, Friedhelm

    Nephron Clinical Practice

    2012  Volume 120, Issue 3, Page(s) c139–c146

    Abstract: Background: Congenital nephrotic syndrome (CNS) is defined as nephrotic syndrome that manifests within the first 3 months of life. Mutations in the NPHS1 gene encoding nephrin, are a major cause for CNS. Currently, more than 173 different mutations of ... ...

    Institution Department of Pediatrics and Department of Human Genetics, and Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Mich., and Pediatric Nephrology, Phoenix Children’s Hospital, Phoenix, Ariz., USA Department of Medical Biology, Hacettepe University, Ankara, Turkey Pediatric Nephrology, Great Ormond Street Hospital, London, UK Center of Pediatric Nephrology and Transplantation, Cairo University, and Egyptian Group for Orphan Renal Diseases (EGORD), Cairo, Egypt
    Abstract Background: Congenital nephrotic syndrome (CNS) is defined as nephrotic syndrome that manifests within the first 3 months of life. Mutations in the NPHS1 gene encoding nephrin, are a major cause for CNS. Currently, more than 173 different mutations of NPHS1 have been published as causing CNS, affecting most exons. Methods: We performed mutation analysis of NPHS1 in a worldwide cohort of 20 families (23 children) with CNS. All 29 exons of the NPHS1 gene were examined using direct sequencing. New mutations were confirmed by demonstrating their absence in 96 healthy control individuals. Results: We detected disease-causing mutations in 9 of 20 families (45%). Seven of the families showed a homozygous mutation, while two were compound heterozygous. In another 2 families, single heterozygous NPHS1 mutations were detected. Out of 10 different mutations discovered, 3 were novel, consisting of 1 splice site mutation and 2 missense mutations. Conclusion: Our data demonstrate that the spectrum of NPHS1 mutations is still expanding, involving new exons, in patients from a diverse ethnic background.
    Keywords Mutation analysis ; Congenital nephrotic syndrome ; NPHS1
    Language English
    Publishing date 2012-05-11
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Original Paper
    ZDB-ID 207121-6
    ISSN 1660-2110 ; 1423-0186 ; 2235-3186 ; 1660-8151 ; 0028-2766
    ISSN (online) 1660-2110 ; 1423-0186 ; 2235-3186
    ISSN 1660-8151 ; 0028-2766
    DOI 10.1159/000337379
    Database Karger publisher's database

    More links

    Kategorien

  8. Article ; Online: Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS).

    Schoeb, Dominik S / Chernin, Gil / Heeringa, Saskia F / Matejas, Verena / Held, Susanne / Vega-Warner, Virginia / Bockenhauer, Detlef / Vlangos, Christopher N / Moorani, Khemchand N / Neuhaus, Thomas J / Kari, Jameela A / MacDonald, James / Saisawat, Pawaree / Ashraf, Shazia / Ovunc, Bugsu / Zenker, Martin / Hildebrandt, Friedhelm

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

    2010  Volume 25, Issue 9, Page(s) 2970–2976

    Abstract: Background: Recessive mutations in the NPHS1 gene encoding nephrin account for approximately 40% of infants with congenital nephrotic syndrome (CNS). CNS is defined as steroid-resistant nephrotic syndrome (SRNS) within the first 90 days of life. ... ...

    Abstract Background: Recessive mutations in the NPHS1 gene encoding nephrin account for approximately 40% of infants with congenital nephrotic syndrome (CNS). CNS is defined as steroid-resistant nephrotic syndrome (SRNS) within the first 90 days of life. Currently, more than 119 different mutations of NPHS1 have been published affecting most exons.
    Methods: We here performed mutational analysis of NPHS1 in a worldwide cohort of 67 children from 62 different families with CNS.
    Results: We found bi-allelic mutations in 36 of the 62 families (58%) confirming in a worldwide cohort that about one-half of CNS is caused by NPHS1 mutations. In 26 families, mutations were homozygous, and in 10, they were compound heterozygous. In an additional nine patients from eight families, only one heterozygous mutation was detected. We detected 37 different mutations. Nineteen of the 37 were novel mutations (approximately 51.4%), including 11 missense mutations, 4 splice-site mutations, 3 nonsense mutations and 1 small deletion. In an additional patient with later manifestation, we discovered two further novel mutations, including the first one affecting a glycosylation site of nephrin.
    Conclusions: Our data hereby expand the spectrum of known mutations by 17.6%. Surprisingly, out of the two siblings with the homozygous novel mutation L587R in NPHS1, only one developed nephrotic syndrome before the age of 90 days, while the other one did not manifest until the age of 2 years. Both siblings also unexpectedly experienced an episode of partial remission upon steroid treatment.
    MeSH term(s) Cohort Studies ; Exons/genetics ; Family ; Female ; Genotype ; Global Health ; Heterozygote ; Homozygote ; Humans ; Infant ; Infant, Newborn ; Male ; Membrane Proteins/genetics ; Mutation/genetics ; Nephrotic Syndrome/congenital ; Nephrotic Syndrome/genetics ; Nephrotic Syndrome/pathology ; Phenotype ; Prognosis
    Chemical Substances Membrane Proteins ; nephrin
    Language English
    Publishing date 2010-02-18
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 90594-x
    ISSN 1460-2385 ; 0931-0509
    ISSN (online) 1460-2385
    ISSN 0931-0509
    DOI 10.1093/ndt/gfq088
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.

    Gee, Heon Yung / Saisawat, Pawaree / Ashraf, Shazia / Hurd, Toby W / Vega-Warner, Virginia / Fang, Humphrey / Beck, Bodo B / Gribouval, Olivier / Zhou, Weibin / Diaz, Katrina A / Natarajan, Sivakumar / Wiggins, Roger C / Lovric, Svjetlana / Chernin, Gil / Schoeb, Dominik S / Ovunc, Bugsu / Frishberg, Yaacov / Soliman, Neveen A / Fathy, Hanan M /
    Goebel, Heike / Hoefele, Julia / Weber, Lutz T / Innis, Jeffrey W / Faul, Christian / Han, Zhe / Washburn, Joseph / Antignac, Corinne / Levy, Shawn / Otto, Edgar A / Hildebrandt, Friedhelm

    The Journal of clinical investigation

    2013  Volume 123, Issue 8, Page(s) 3243–3253

    Abstract: Nephrotic syndrome (NS) is divided into steroid-sensitive (SSNS) and -resistant (SRNS) variants. SRNS causes end-stage kidney disease, which cannot be cured. While the disease mechanisms of NS are not well understood, genetic mapping studies suggest a ... ...

    Abstract Nephrotic syndrome (NS) is divided into steroid-sensitive (SSNS) and -resistant (SRNS) variants. SRNS causes end-stage kidney disease, which cannot be cured. While the disease mechanisms of NS are not well understood, genetic mapping studies suggest a multitude of unknown single-gene causes. We combined homozygosity mapping with whole-exome resequencing and identified an ARHGDIA mutation that causes SRNS. We demonstrated that ARHGDIA is in a complex with RHO GTPases and is prominently expressed in podocytes of rat glomeruli. ARHGDIA mutations (R120X and G173V) from individuals with SRNS abrogated interaction with RHO GTPases and increased active GTP-bound RAC1 and CDC42, but not RHOA, indicating that RAC1 and CDC42 are more relevant to the pathogenesis of this SRNS variant than RHOA. Moreover, the mutations enhanced migration of cultured human podocytes; however, enhanced migration was reversed by treatment with RAC1 inhibitors. The nephrotic phenotype was recapitulated in arhgdia-deficient zebrafish. RAC1 inhibitors were partially effective in ameliorating arhgdia-associated defects. These findings identify a single-gene cause of NS and reveal that RHO GTPase signaling is a pathogenic mediator of SRNS.
    MeSH term(s) Animals ; Base Sequence ; Case-Control Studies ; Cell Movement ; Cells, Cultured ; Chromosome Mapping ; Consanguinity ; Gene Knockdown Techniques ; Genetic Association Studies ; Homozygote ; Humans ; Mutation, Missense ; Nephrotic Syndrome/enzymology ; Nephrotic Syndrome/genetics ; Nephrotic Syndrome/pathology ; Podocytes/metabolism ; Podocytes/physiology ; Protein Binding ; Protein Interaction Mapping ; Protein Transport ; Sequence Analysis, DNA ; Signal Transduction ; Zebrafish ; cdc42 GTP-Binding Protein/metabolism ; rac1 GTP-Binding Protein/metabolism ; rho Guanine Nucleotide Dissociation Inhibitor alpha/genetics ; rho Guanine Nucleotide Dissociation Inhibitor alpha/metabolism ; rhoA GTP-Binding Protein/metabolism
    Chemical Substances ARHGDIA protein, human ; RAC1 protein, human ; rho Guanine Nucleotide Dissociation Inhibitor alpha ; RHOA protein, human (124671-05-2) ; cdc42 GTP-Binding Protein (EC 3.6.5.2) ; rac1 GTP-Binding Protein (EC 3.6.5.2) ; rhoA GTP-Binding Protein (EC 3.6.5.2)
    Language English
    Publishing date 2013-07-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI69134
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A systematic approach to mapping recessive disease genes in individuals from outbred populations.

    Hildebrandt, Friedhelm / Heeringa, Saskia F / Rüschendorf, Franz / Attanasio, Massimo / Nürnberg, Gudrun / Becker, Christian / Seelow, Dominik / Huebner, Norbert / Chernin, Gil / Vlangos, Christopher N / Zhou, Weibin / O'Toole, John F / Hoskins, Bethan E / Wolf, Matthias T F / Hinkes, Bernward G / Chaib, Hassan / Ashraf, Shazia / Schoeb, Dominik S / Ovunc, Bugsu /
    Allen, Susan J / Vega-Warner, Virginia / Wise, Eric / Harville, Heather M / Lyons, Robert H / Washburn, Joseph / Macdonald, James / Nürnberg, Peter / Otto, Edgar A

    PLoS genetics

    2009  Volume 5, Issue 1, Page(s) e1000353

    Abstract: The identification of recessive disease-causing genes by homozygosity mapping is often restricted by lack of suitable consanguineous families. To overcome these limitations, we apply homozygosity mapping to single affected individuals from outbred ... ...

    Abstract The identification of recessive disease-causing genes by homozygosity mapping is often restricted by lack of suitable consanguineous families. To overcome these limitations, we apply homozygosity mapping to single affected individuals from outbred populations. In 72 individuals of 54 kindred ascertained worldwide with known homozygous mutations in 13 different recessive disease genes, we performed total genome homozygosity mapping using 250,000 SNP arrays. Likelihood ratio Z-scores (ZLR) were plotted across the genome to detect ZLR peaks that reflect segments of homozygosity by descent, which may harbor the mutated gene. In 93% of cases, the causative gene was positioned within a consistent ZLR peak of homozygosity. The number of peaks reflected the degree of inbreeding. We demonstrate that disease-causing homozygous mutations can be detected in single cases from outbred populations within a single ZLR peak of homozygosity as short as 2 Mb, containing an average of only 16 candidate genes. As many specialty clinics have access to cohorts of individuals from outbred populations, and as our approach will result in smaller genetic candidate regions, the new strategy of homozygosity mapping in single outbred individuals will strongly accelerate the discovery of novel recessive disease genes.
    MeSH term(s) DNA Mutational Analysis ; False Positive Reactions ; Family Health ; Female ; Genes, Recessive ; Genetic Markers ; Genetics, Population ; Homozygote ; Humans ; Kidney Diseases, Cystic/genetics ; Male ; Models, Genetic ; Nephrotic Syndrome/genetics ; Pedigree ; Steroids/pharmacology
    Chemical Substances Genetic Markers ; Steroids
    Language English
    Publishing date 2009-01-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2186725-2
    ISSN 1553-7404 ; 1553-7390
    ISSN (online) 1553-7404
    ISSN 1553-7390
    DOI 10.1371/journal.pgen.1000353
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top